Skip to content

Hair

Care, styling, and the slow-moving HRT changes for scalp hair. Three things move at once on a trans-feminine head: the androgenetic alopecia (AGA) trajectory that started before HRT, the partial slowing of that trajectory once estradiol is on board and serum testosterone is suppressed, and a per-strand texture and diameter shift that unfolds over the first two to three years. Daily care fundamentals — wash, condition, trim, protect from heat — are unchanged from generic feminine-hair advice; the trans-specific load is loss management, texture-shift adjustment, and the wig or topper question for patients with established loss.

This page is scoped to scalp hair. Body and facial hair removal lives on Hair Removal; the systemic AAs that double as hair-loss drugs are profiled on Anti-Androgens; transplant and hairline-advancement surgery sit under Hair Transplant and Hairline Advancement. Cross-links appear inline where the topic matters.

Hair typing

Two systems are in common use. Neither is a clinical instrument; both are shorthand for product selection and styling.

Andre Walker (1990s). Four numeric types with sub-letters a/b/c inside types 2–4:

  • Type 1 — straight. No discernible curl. 1a fine and limp, 1b medium body, 1c coarse and resistant.
  • Type 2 — wavy. S-shaped pattern that emerges when air-dried. 2a loose beach wave, 2b defined mid-shaft wave, 2c tight wave bordering on curl.
  • Type 3 — curly. Spiral or corkscrew with a visible loop. 3a loose large-loop, 3b springy medium-loop, 3c tight small-loop bordering on coil.
  • Type 4 — coily. Tight zigzag or spring pattern. 4a defined springy coil, 4b sharp Z-pattern, 4c densely packed and least defined.

Most heads carry two types — for example, 3a at the crown and 2c at the nape. The number describes the dominant pattern.

LOIS (community-built). Four axes — strand shape (L/O/I/S), strand size (thin/medium/thick), texture (cottony, spongy, wiry, silky, thready), and elasticity (high/normal/low). More useful for product diagnostics ("why does my hair refuse to absorb conditioner?") than for cut decisions.

Identifying your type. Wash, apply no product, air-dry without manipulation, and look. Hair behaves as its native type only when fully clean and unweighted. Heat-styling habits and product residue mask the underlying pattern. Many trans-feminine patients discover, after stopping daily flat-iron use, that the hair underneath is wavier than it appeared.

Type can shift on HRT. Two changes show up consistently: strand diameter decreases ("hair feels finer"), and curl pattern often tightens or appears (straight to wavy, wavy to more clearly so). The mechanism is not formally established. Plausible contributors are altered follicle shape from changed androgen tone, altered sebum production changing strand weight, and reduced cuticle thickness. A 2a hair at HRT start may read as a 2b–2c by year three. The shift is slow enough that most people notice it retrospectively from photos rather than week-to-week.

What HRT does to scalp hair

Five durable changes show up on standard feminizing HRT (estradiol plus antiandrogen targeting serum total testosterone <50 ng/dL — Hembree 2017, WPATH SOC v8).

1. Slowed but rarely reversed AGA. The miniaturization process that produces male-pattern recession is DHT-driven. Lowering DHT exposure halts further loss, but already-miniaturized follicles regrow unreliably. Temple recession and the frontotemporal "M-shape" established during male puberty are structural — a hairline shape, not just a density — and remain visible after years on HRT. Vertex thinning often improves more than frontal/temporal recession because the crown follicles have typically miniaturized for less time. Background: AAD on androgenetic alopecia; Olsen 2005 on AGA in women.

2. Texture shift. Most commonly, straighter hair becomes wavier or existing curl tightens. A subset report the opposite; the asymmetry favors the toward-curl direction. The shift unfolds over 1–2 years and is most noticeable when growing out a cut that was made on the pre-HRT texture.

3. Strand-diameter decrease. Independent of overall density. A patient with thick coarse hair pre-HRT typically reports the same number of strands per square centimeter, with each strand thinner.

4. Sebum reduction. Estrogen-dominant hormonal milieu produces less sebum across all sebaceous skin, scalp included. Wash frequency that was appropriate pre-HRT is often too frequent by year two; many patients shift to every 2–3 days without scalp greasiness. The parallel facial-sebum effect is on Skin.

5. Body and facial hair slows. Covered on Hair Removal. Briefly: terminal body hair becomes finer and slower-growing; facial-hair density decreases minimally, which is why permanent removal remains necessary for most patients. The scalp-vs-body asymmetry — HRT slows scalp loss and slows body growth — is exactly the desired pattern, achieved by different mechanisms in each region.

Timeline. Most changes start at 6–12 months on stable HRT and continue to evolve for 2+ years. The "final" hair state on HRT is usually not knowable before year three — see Candidacy and Timing for why this matters when transplant is on the table. Patient-reported outcomes and density tracking come from Gao 2018 and Stevenson 2019.

Care fundamentals

Standard practical hair care, with HRT-specific notes flagged. The trans-specific note that matters across this section: sebum reduction at year 1+ on HRT usually allows extending wash intervals by one bracket compared to the pre-HRT habit.

Wash frequency. Keep the scalp neither greasy nor irritated.

Type Typical frequency Notes
1 (straight) every 1–3 days sebum reaches ends fast; under-washing → lank
2 (wavy) every 1–3 days similar, with more variation by strand size
3 (curly) every 3–7 days curl pattern fragments under frequent washing
4 (coily) every 7–14 days drought-prone cuticle; co-wash in between

Shampoo. Sulfate-based (sodium lauryl/laureth sulfate) strips oil and residue — appropriate for oily scalps and weekly clarification, too harsh as daily shampoo on finer or curlier hair. Sulfate-free (cocamidopropyl betaine, decyl glucoside, sodium cocoyl-isethionate) is milder and curl/color-friendly, appropriate for everyday use. Clarifying shampoos add chelating agents (EDTA, citric acid) for hard-water buildup; use every 2–4 weeks. Co-washing (conditioner only) is common in type 3–4 routines and does not work for high-sebum scalps.

Conditioner. Rinse-out daily; leave-in for slip and ongoing moisture (light sprays for finer hair, heavier creams for coarser); deep conditioner or mask weekly to bi-weekly for chemically-treated or heat-damaged hair. Weight match is more about strand diameter than curl pattern — finer post-HRT hair tolerates only light products; heavy butters (shea, mango) flatten the strand.

Scalp care. Massage 1–3 minutes during shampoo. Exfoliate physically or chemically (salicylic acid scalp serum) every 2–4 weeks for buildup-prone scalps. Scalp serums (niacinamide, peptide blends, low-concentration retinol, caffeine) are marketed for growth but the evidence is thin for anything beyond minoxidil. Avoid heavy oils and butters on the scalp itself (rather than ends); they trap sebum and feed yeast, and seborrheic dermatitis is common and worth treating with antifungal shampoo (ketoconazole 1–2%) at first sign.

Heat protection. Any heat tool above ~150 °F damages the cuticle without protection. Silicone-based protectants (dimethicone, cyclomethicone) form a thin film that distributes heat. Spray is lighter; cream gives more substantive protection on coarser hair. Apply to damp hair before drying, and again before iron use; the film breaks down with repeated heat cycles.

Trims. Every 6–12 weeks regardless of length goal. Split ends migrate up the strand if not trimmed, eventually forcing more length removal than regular maintenance would have. "Dusting" — removing only the very ends (0.25–0.5 cm) — suffices for length-preservation goals; a full trim (1–3 cm) is needed every 3–6 months.

Cuts and styling

Face shape. Standard six-shape framework, applied as heuristics: oval takes most cuts; round wants vertical length (long layers, side parts, crown height); square wants softening (waves, layers ending below the jaw, side-swept bangs); heart wants width at the jaw (chin-length bob, layers starting at the chin); oblong wants horizontal width (waves, blunt bangs); diamond wants softened cheekbones plus forehead volume (curtain bangs, soft face-framing layers).

Hairline shape after AGA, FFS, or transplant is often a stronger constraint on workable cuts than face shape. Order: hairline first, density second, face shape third.

Length tradeoffs.

Length Commitment Maintenance Daily styling
Pixie / very short Low to grow out High (frequent trims) Low
Bob (jaw–shoulder) Medium Medium Medium
Mid-length Higher Lower High
Long (past collarbone) Highest Low–medium Highest

Bangs. Full/blunt is high commitment, suits oblong and heart, needs straight-to-wavy texture or consistent styling. Side bangs are softer and lower commitment, work on most shapes. Curtain bangs (center-parted, length-graduated) are widely flattering with the lowest growing-out awkwardness. All bangs trim every 3–4 weeks.

Layers. Internal layers remove bulk from thick hair without changing the silhouette. Surface/face-framing layers shape the cheekbone framing. Long layers preserve length; short layers (shag, wolf cut) create texture and volume at the cost of committing to that shape. Finer post-HRT hair often benefits from fewer layers, since each layer removes density at the ends.

Color. Permanent dye opens the cuticle and lasts until grown out (most damage). Semi-permanent coats the strand and fades over 4–8 weeks (minimal damage). Temporary washes out in 1–4 washes (useful for testing). Box dye is cheaper but harder to predict, especially for color-correction or going lighter; salon allows tone-matching and staged lightening; box dye over chemically-treated hair risks unpredictable reactions. Bleaching to platinum risks hygral fatigue and breakage; the lift schedule (lightening over multiple sessions, weeks apart) protects integrity but requires patience. Finer post-HRT hair bleaches with more damage than coarser pre-HRT hair at the same developer concentration.

Heat tools. Round brush plus dryer (medium round 40–50 mm for shoulder-length, larger for longer; concentrator nozzle, medium heat, cool-shot to set) is the workhorse. Curling iron / wand barrel sizes: 19 mm tight, 25 mm medium, 32 mm loose; 300–350 °F for finer hair, 350–400 °F for coarser, never above 410 °F. Flat iron for straightening or soft-bend curls, same temperature brackets; ceramic plates are gentler and less precise, titanium faster and more damaging if mishandled, tourmaline in between. Hot rollers (set in dry hair, cool in place 10–20 minutes) are a lower-damage, less-precise alternative. Heat protection is mandatory throughout.

Heatless. Overnight curls (damp hair wrapped around a satin headband, soft rollers, or flexi-rods); braids on damp hair undone in the morning; two- or three-strand twists dried and untwisted; pin curls (small sections coiled and pinned). Time investment moves from morning to evening.

Protective styles. Low buns, top buns, French twists, and braided crowns reduce daily friction on the lengths and protect color. For type 3–4 hair, full protective styles (box braids, twists, faux locs) extend between-wash intervals to 2–6 weeks.

Growth timeline. Scalp hair grows ~0.5 inch per month, ~6 inches per year, varying by genetics and health. Plan in 6-month increments per 6 inches. Transitions between lengths usually require an "ugly phase" where the prior cut is growing out and the next length is not yet established; mid-length intermediate cuts and accessories (clips, headbands, light extensions) bridge this period.

Hair loss management

This is the section where the operational stakes are highest, because the choices made early determine what is recoverable later.

HRT alone rarely reverses established loss

Lowering serum testosterone halts the DHT-driven miniaturization that drives male-pattern AGA, but already-miniaturized follicles regrow unreliably. The recession that was visible at HRT initiation is usually still visible at year five, sometimes with modest diffuse-density improvement at the vertex and minimal change at the temples. Active loss management starts at the same time HRT starts — not after waiting two years to "see what HRT does."

The fundamentals: minoxidil 5% topical is first-line; finasteride or dutasteride adds direct DHT blockade when systemic AA suppression is inadequate; transplant is a question for stable, established loss after maximal medical management, not a substitute for it. Background reading: Cochrane review on minoxidil for AGA; Cochrane review on finasteride; Mella 2010 on finasteride efficacy; Olsen 2002 on minoxidil 5% and Olsen 2005 on AGA management in women. Trichology textbook treatments by Tosti/Piraccini, Sinclair/Patel, and Trüeb cover the same ground in book form.

The treatment ladder

A working order-of-operations. Each step assumes the previous one is in place; nothing replaces what came before.

Step Intervention Evidence base Setup Onset Maintenance When to add
1 Topical minoxidil 5% RCTs, Cochrane OTC 3–6 months indefinite any active or stabilized AGA
2 Oral finasteride or dutasteride RCTs, Cochrane prescription 3–6 months indefinite scalp loss continuing despite systemic AA
2a Topical finasteride / dutasteride small RCTs compounded 3–6 months indefinite systemic 5-AR contraindicated or unwanted
3 Microneedling (with minoxidil) small RCTs DIY or clinic 3–6 months weekly–biweekly plateau on steps 1–2
4 Platelet-rich plasma (PRP) small RCTs clinic 3–6 months every 6–12 mo plateau on steps 1–3, willing to pay
5 Hair transplant clinical, large surgery 6–12 months indefinite Rx stable established loss after 18–24 mo HRT + steps 1–2

Low-level laser therapy (red-spectrum caps and helmets) sits next to the ladder rather than on it: FDA-cleared for AGA, with limited evidence and small effect sizes; reasonable as an adjunct, not a substitute.

Topical minoxidil 5%

First-line topical for any active or stabilized AGA in trans-feminine patients. Mechanism is ATP-sensitive potassium-channel opening, dermal-papilla vasodilation, and modulation of the hair cycle to prolong anagen and shorten telogen; the exact regrowth mechanism is not fully established. Formulations come as liquid (propylene-glycol vehicle, may irritate sensitive scalps) and foam (no propylene glycol, cosmetically lighter, often preferred for daily use); both are 5%. Once-daily produces some benefit, twice-daily more (at greater inconvenience); many patients settle on once-daily for long-term adherence with twice-daily reasonable during the establishment phase.

Visible results take 3–6 months minimum. The first 1–2 months often produce a shedding phase — a paradoxical increase in shed hairs as miniaturized follicles synchronize and re-enter anagen — which is expected and not a reason to discontinue. Continued use is required: stopping minoxidil produces gradual loss of the regrown hair over 3–6 months. The drug holds the result; it does not cure the underlying AGA. Apply to dry or towel-dried scalp (not hair), rub in, wash hands, and do not wash hair for 4 hours afterwards.

Finasteride and dutasteride

DHT suppression at the level of 5α-reductase. The trans-specific dosing context lives on Anti-Androgens; what follows is the hair-specific summary. Finasteride 1 mg/day oral is a Type II 5α-R inhibitor that lowers serum DHT ~70% (the standard cis-male AGA dose). Dutasteride 0.5 mg/day oral inhibits Types I and II, lowering DHT >90%; head-to-head superior to finasteride for vertex AGA in cis-male studies. Topical finasteride / dutasteride are increasingly used at lower systemic exposure than oral; topical finasteride has small RCTs, topical dutasteride is earlier in the pipeline, both sourced via compounding pharmacies with variable product quality. Onset is 3–6 months to visible effect, 12 months to maximum effect, with continued use required (stopping reverses suppression and AGA resumes).

Trans-feminine context: adding finasteride or dutasteride is most clearly indicated when scalp loss continues despite adequate systemic suppression — a sign that scalp DHT conversion is locally elevated and warrants direct 5-AR blockade. Patients on a primary AA that already produces strong DHT suppression (high-dose CPA, post-orchiectomy state) often need less or no added 5-AR inhibitor.

Topical antiandrogens

Less-established evidence; community-popular; sourcing concerns flagged. RU58841 is a research-chemical topical AR antagonist not approved for human use in any jurisdiction, sourced from research-chemical vendors with no quality control; anecdotal efficacy is high but published human data are essentially absent. Topical finasteride / dutasteride are compounded preparations via online or community-recommended compounders (see above). Topical spironolactone has a small evidence base; reduces local AR signaling without systemic effect. Research-chemical topicals are unregulated, quality varies dramatically by source, and dermatologic supervision is appropriate before adding any topical AA to a regimen that already includes systemic ones. The safety floor here is considerably lower than for OTC minoxidil or prescribed oral 5-AR inhibitors.

Microneedling

Emerging evidence base; often combined with minoxidil to enhance penetration and trigger a growth-factor cascade. Use 0.5–1.5 mm needle length for scalp (below 0.5 mm is largely cosmetic; above 1.5 mm risks scarring and infection without clear added benefit), weekly to bi-weekly (daily is too aggressive). Most studies pair microneedling with topical minoxidil 5% applied immediately after; the combination has small positive RCTs. Sterilize the device between sessions, replace heads per manufacturer, and do not microneedle over active acne or inflamed scalp.

Platelet-rich plasma (PRP)

Specialist-administered: blood drawn, centrifuged, platelet-rich fraction injected into the scalp. Evidence is modest — multiple small RCTs show density improvement vs saline; long-term durability and protocol standardization are unsettled. Mechanism is platelet-derived growth factors (PDGF, VEGF, others) modulating the hair cycle locally. Cost runs \(400–\)1,500 per session in the US, with a series of 3–4 sessions initially and maintenance every 6–12 months. Most often added to minoxidil + finasteride/dutasteride for patients who plateaued on those alone.

Hair transplant

Surgical redistribution of androgen-resistant donor follicles to the recipient zone. The full clinical treatment lives under Hair Transplant; FUE vs FUT, Candidacy and Timing, and Combining with FFS cover the procedural detail. Standard textbook coverage in Unger and Shapiro, Hair Transplantation, and Bouhanna and Bouhanna, The Alopecias.

The hair-page-relevant points: transplant is not a substitute for medical management — native non-transplanted hairs in the recipient zone continue to miniaturize on whatever AGA trajectory the patient is on, and transplant without medical stabilization produces a "halo" of grafts surrounded by progressive native loss. Most surgeons require 18–24 months of stable HRT before transplant evaluation, both to let HRT do its work on miniaturization and to characterize what is left. Donor capacity is finite: lifetime donor yield is roughly 5,000–8,000 follicular units, and a complete frontal + mid-scalp restoration at conservative density needs 4,000–6,000.

Scarring alopecias — different category

Not AGA; do not respond to minoxidil/finasteride/dutasteride; require dermatologic workup, often with biopsy. Frontal fibrosing alopecia (FFA) is a postmenopausal-female-predominant scarring alopecia at the frontotemporal hairline; there is biological plausibility for elevated risk in long-term-estrogen trans-feminine patients but it is not formally studied. Lichen planopilaris (LPP) is patchy scarring alopecia with perifollicular erythema and scale. Central centrifugal cicatricial alopecia (CCCA) is a progressive central scarring alopecia, more common in patients of African descent. Discoid lupus erythematosus is autoimmune and can produce scarring scalp patches. Any patient with rapidly progressing loss, perifollicular erythema, scaling, or burning/itching should be referred to dermatology before assuming AGA.

Decision tree

What the operational logic looks like in practice:

  1. Loss active and AGA-pattern? Minoxidil 5% topical first; add finasteride or dutasteride if not adequately suppressed by existing systemic AA. Reassess at 6 and 12 months.
  2. Loss stable and established? Consider transplant after 18–24 months stable HRT and at least 6–12 months on minoxidil + adequate AA.
  3. Loss extensive (Norwood ≥VI underlying)? Realistic candidate for partial restoration only; donor capacity is the limit. Wig or hair system may be the more durable answer; FFS hairline advancement may close some of the gap if anatomy permits.
  4. Loss not AGA-pattern? Dermatology workup before treatment.

Wigs

A legitimate permanent solution, a legitimate transition aid, and a legitimate fallback for patients who are not transplant candidates. Wigs have shed most of their historical stigma in the trans-feminine community, where they are recognized as practical infrastructure rather than a marker of "incomplete" transition.

Synthetic vs human hair.

Dimension Synthetic Human hair
Cost \(50–\)300 \(300–\)3,000+
Lifespan (daily) 3–6 months 1–3 years
Heat tolerance None (low-grade) to ~300 °F (heat-friendly) Full — same as biological hair
Style memory High — keeps cut shape after wash Low — restyle each wash
Texture options Wide Wide
Realism close-up Lower (uniform fiber) Higher

Daily long-term wear often pencils out cheaper with human hair despite the higher upfront cost. Synthetic is appropriate for occasional wear, color experimentation, or transition-period bridging.

Hairline and cap construction. Lace-front caps have sheer lace at the hairline with individual hairs hand-tied through, producing a natural-looking hairline that can be parted in any direction (higher cost, more delicate). Standard wefted-front caps show a visible front line that usually requires bangs or a styled-forward fringe to conceal. Within the cap itself: wefted (machine-made) is most affordable and durable, least flexible in styling; monofilament-top has fine mesh at the crown allowing multi-direction parting with the rest of the cap wefted (mid-range); full lace allows updos and ponytails (most expensive); hand-tied is the lightest with the most natural movement (highest cost).

Density and fit. Density runs light, medium, full. Most natural hair sits near medium; off-the-shelf wigs are often denser than natural hair to look "full" in product photos but read as wig-like in person, and reducing density (thinning shears, professional customization) is a common adjustment. For fit, measure head circumference (around the largest part, just above the ears and at the brow), front-to-nape, and ear-to-ear; standard sizes are petite (~21"), average (~22"), and large (~22.5–23"). Too-large is more common than too-small and produces visible shifting; custom-fit options exist at higher price points.

Care basics. Wash synthetic every 6–10 wears, human hair every 7–14 wears (more often with daily sweat). Store on a wig stand or canvas head; folded storage creates creases. Brush with a wide-tooth comb or wig brush from the ends up, never roots-down, and detangle dry rather than wet.

Where to buy. Community-trusted vendors are the right answer; specific shop names age out fast and are best sourced from current community threads. Categories: dedicated trans-friendly wig shops (online and in larger cities); general human-hair vendors; cosplay/synthetic vendors for color experimentation. Avoid no-name marketplace listings without return policies.

Adhesive vs non-adhesive. Combs, clips, adjustable straps, and wig-grip headbands are sufficient for most daily wear and low-impact activity. Wig glue or tape (lace-front) is more secure for active wear, swimming, and performance; it requires solvent for removal and risks scalp irritation and hairline traction loss if used continuously.

Wig as transition aid vs permanent solution. Wig wear during early transition while medical management catches up is common and not a sign of failure; many patients reduce wig use as HRT, minoxidil, and (where applicable) transplant outcomes mature. A subset settle on wigs as the permanent solution because the result is reliable and the lifestyle is acceptable — a legitimate end-state, not a halfway house.

Extensions and toppers

For partial loss or volume augmentation short of full wig coverage. Clip-in extensions are wefts with attached clips, applied and removed daily — no commitment, no adhesive, lowest impact on natural hair, appropriate for length and density augmentation but not for hairline coverage. Tape-in wefts adhere for 6–8 weeks and are then re-taped; low visibility, semi-permanent, some tension risk if installed tight. Sew-in wefts go onto a braided base for 6–10 weeks (more secure, more tension). Microbead wefts attach individually with silicone-lined beads for 8–12 weeks (no adhesive or sewing, tension risk similar to sew-in). Toppers clip onto the scalp at the area of thinning (typically crown or part line) — smaller and lighter than a wig, useful for Ludwig-pattern central thinning or for crown coverage while medical management matures.

Extensions are augmentation, not protection; continuous tension at attachment points produces traction alopecia. Conservative practice is 2–4 weeks off between installation cycles, alternating attachment points, and discontinuing at the first sign of thinning along the attachment line. Already-fragile post-bleach or post-chemical-treatment hair raises the risk.

Specific situations

FFS hairline advancement. See Hairline Advancement for the procedure. Hair-care implications: the advanced-hairline scar lies just behind the new hairline and is initially numb. Gentle washing and styling for the first 6–12 weeks; avoid heat directly over the scar for 3 months; the trichophytic edge produces hair growth through the scar over 3–9 months that softens its visibility.

Hair transplant recovery. See Recovery for the full restriction schedule. Early post-op is highly restricted (no shampoo for 48–72 hours; gentle saline rinses thereafter; no rubbing, heat, or product on the recipient zone for 2 weeks; no swimming for 2–4 weeks). Grafted hairs shed at 2–6 weeks (telogen synchronization) and regrow at 3–6 months. Standard practice continues minoxidil + finasteride/dutasteride indefinitely after transplant to preserve native non-transplanted hair; some surgeons pause minoxidil for 1–2 weeks around surgery to reduce scalp vasodilation, and protocol varies.

Wigs in early transition. A bridge during years 0–3 of HRT, when texture is still shifting and AGA management is still maturing. Practical for patients who started transition with extensive existing loss and do not want to wait for medical or surgical results.

Cancer-treatment alopecia. Chemotherapy-induced alopecia is acute, total or near-total, and usually reversible (regrowth 3–6 months post-treatment, often with texture change). HRT continuity through treatment is a separate question. Wigs during treatment are routine; many cancer centers offer wig- fitting services free or at low cost.

Common mistakes

  • Over-bleaching. Repeated bleach to platinum on finer post-HRT hair produces breakage that is not recoverable without significant length loss.
  • Ignoring the scalp. Treating only strands and never scalp produces buildup, seborrheic dermatitis, and an environment that does not support healthy follicle function.
  • Skipping heat protection. Daily flat-iron or curling-iron use without protectant produces cumulative cuticle damage that masquerades as "my hair is just dry" — and cannot be conditioned away once the cuticle is gone.
  • Expecting HRT alone to reverse loss. The most common single miscalibration in the trans-feminine hair literature. HRT slows AGA; it does not reverse established miniaturization on a useful timescale for most patients.
  • Going too long between trims. Split ends migrate; eventually the damaged length must be cut off, undoing months of growth.
  • Wig too dense. Off-the-shelf wigs are often denser than natural hair; the "perfect" out-of-box wig usually reads as a wig.
  • Adhesive overuse. Daily wig-glue at the hairline produces traction loss and scalp irritation; non-adhesive secure wear is sufficient for most daily contexts.
  • Skin — sebum reduction, scalp dermatitis context, undertone shift.
  • Makeup — face-shape and bone-structure framing that interacts with cut and hairline choices.
  • Hair Removal — the body- and facial-hair counterpart.
  • Anti-Androgens — finasteride, dutasteride, and the systemic AAs whose DHT suppression matters for scalp.
  • Hair Transplant — surgical restoration, candidacy, and recovery.
  • Hairline Advancement — the FFS alternative for high or M-shape hairlines.
  • Presentation index — sibling pages in the same register.

Sources

Primary references kept with URLs:

Author-title references (textbooks and reviews, no URL):

  • Unger WP, Shapiro R, eds. Hair Transplantation, 5th ed. — standard textbook reference for transplant practice.
  • Bouhanna P, Bouhanna E. The Alopecias: Diagnosis and Treatments — trichology textbook.
  • Sinclair R, Patel M. Female-pattern hair-loss reviews — Ludwig-pattern AGA management.
  • Tosti A, Piraccini BM. Diagnosis and Treatment of Hair Disorders — trichology textbook.
  • Trüeb RM. "Aging of hair" — dermatologic review series.